Drug billing continues to be a high-risk area for ophthalmology practices. In this episode, Mary Pat Johnson and Rebecca Greenlaw discuss key considerations related to ophthalmology J-codes, including modifier use, dosing accuracy, Medicare reimbursement, and how drug billing decisions can affect performance under MIPS. This practical conversation is designed to help practices reduce audit risk and strengthen compliance.